211 related articles for article (PubMed ID: 22279443)
21. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.
Emi N; Friedmann T; Yee JK
J Virol; 1991 Mar; 65(3):1202-7. PubMed ID: 1847450
[TBL] [Abstract][Full Text] [Related]
22. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
[TBL] [Abstract][Full Text] [Related]
23. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines.
Arai T; Matsumoto K; Saitoh K; Ui M; Ito T; Murakami M; Kanegae Y; Saito I; Cosset FL; Takeuchi Y; Iba H
J Virol; 1998 Feb; 72(2):1115-21. PubMed ID: 9445007
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system.
Suda Y; Fukushi S; Tani H; Murakami S; Saijo M; Horimoto T; Shimojima M
Arch Virol; 2016 Jun; 161(6):1447-54. PubMed ID: 26935918
[TBL] [Abstract][Full Text] [Related]
25. Contributions of the Four Essential Entry Glycoproteins to HSV-1 Tropism and the Selection of Entry Routes.
Hilterbrand AT; Daly RE; Heldwein EE
mBio; 2021 Mar; 12(2):. PubMed ID: 33653890
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors.
Fang X; Zhang S; Sun X; Li J; Sun T
Vaccine; 2012 Feb; 30(7):1313-21. PubMed ID: 22222871
[TBL] [Abstract][Full Text] [Related]
27. Preparation of vesicular stomatitis virus-G (VSV-G) conjugate and its use in gene transfer.
Miyanohara A
Cold Spring Harb Protoc; 2012 Apr; 2012(4):453-6. PubMed ID: 22474657
[TBL] [Abstract][Full Text] [Related]
28. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
29. Use of a recombinant murine cytomegalovirus expressing vesicular stomatitis virus G protein to pseudotype retroviral vectors.
Manning WC; Murphy JE; Jolly DJ; Mento SJ; Ralston RO
J Virol Methods; 1998 Jul; 73(1):31-9. PubMed ID: 9705172
[TBL] [Abstract][Full Text] [Related]
30. Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins.
Lay Mendoza MF; Acciani MD; Levit CN; Santa Maria C; Brindley MA
Viruses; 2020 Dec; 12(12):. PubMed ID: 33348746
[TBL] [Abstract][Full Text] [Related]
31. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.
Hanika A; Larisch B; Steinmann E; Schwegmann-Weßels C; Herrler G; Zimmer G
J Gen Virol; 2005 May; 86(Pt 5):1455-1465. PubMed ID: 15831958
[TBL] [Abstract][Full Text] [Related]
32. Understanding and altering cell tropism of vesicular stomatitis virus.
Hastie E; Cataldi M; Marriott I; Grdzelishvili VZ
Virus Res; 2013 Sep; 176(1-2):16-32. PubMed ID: 23796410
[TBL] [Abstract][Full Text] [Related]
33. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.
Watson DJ; Kobinger GP; Passini MA; Wilson JM; Wolfe JH
Mol Ther; 2002 May; 5(5 Pt 1):528-37. PubMed ID: 11991743
[TBL] [Abstract][Full Text] [Related]
34. [Vesicular stomatitis virus (VSV) as a vaccine vector for immunization against viral infections].
Tomczyk T; Orzechowska B
Postepy Hig Med Dosw (Online); 2013 Jan; 67():1345-58. PubMed ID: 24379275
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells.
Kaneko H; Suzuki H; Abe T; Miyano-Kurosaki N; Takaku H
Biochem Biophys Res Commun; 2006 Nov; 349(4):1220-7. PubMed ID: 16979590
[TBL] [Abstract][Full Text] [Related]
36. Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1.
Rose NF; Roberts A; Buonocore L; Rose JK
J Virol; 2000 Dec; 74(23):10903-10. PubMed ID: 11069984
[TBL] [Abstract][Full Text] [Related]
37. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.
Meyer K; Basu A; Ray R
Virology; 2000 Oct; 276(1):214-26. PubMed ID: 11022009
[TBL] [Abstract][Full Text] [Related]
38. Pseudotyping of vesicular stomatitis virus with the envelope glycoproteins of highly pathogenic avian influenza viruses.
Zimmer G; Locher S; Berger Rentsch M; Halbherr SJ
J Gen Virol; 2014 Aug; 95(Pt 8):1634-1639. PubMed ID: 24814925
[TBL] [Abstract][Full Text] [Related]
39. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein.
Barsoum J; Brown R; McKee M; Boyce FM
Hum Gene Ther; 1997 Nov; 8(17):2011-8. PubMed ID: 9414250
[TBL] [Abstract][Full Text] [Related]
40. Baculovirus GP64-mediated entry into mammalian cells.
Kataoka C; Kaname Y; Taguwa S; Abe T; Fukuhara T; Tani H; Moriishi K; Matsuura Y
J Virol; 2012 Mar; 86(5):2610-20. PubMed ID: 22190715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
